Jonathan Avery

From Wikipedia, the free encyclopedia

Jonathan Avery is an American addiction psychiatrist and academic based at Weill Cornell Medical College.[1] At Weill Cornell, he serves as Vice Chair for Addiction Psychiatry and holds the endowed Stephen P. Tobin and Dr. Arnold M. Cooper Professorship in Consultation Liaison Psychiatry.[2] He is also the medical director of the NBA/NBPA Anti-Drug Program.[2][3]

Avery was born in the U.S. His father was a hospice physician.[4]

Jonathan Avery earned his M.D. from New York University School of Medicine in 2009, followed by a psychiatry residency at NewYork-Presbyterian Hospital / Payne Whitney Clinic, where he was co-chief resident.[2] He later completed a specialization in addiction psychiatry at NYU School of Medicine.

Medical career

After fellowship, Avery joined the faculty at Weill Cornell Medical College and NewYork-Presbyterian Hospital.[1] He is now Program Director for the Addiction Psychiatry Fellowship and Vice Chair for Addiction Psychiatry in the Department of Psychiatry.[4]

He founded the Weill Cornell / New York-Presbyterian Program for Substance Use and Stigma of Addiction. The program was launched in 2019 and focuses on reducing stigma in medical settings, as well as improving intervention strategies.[4] Since 2023, he has been the medical director of the NBA/NBPA Anti-Drug Program.

Research and advocacy

Avery's research topics include clinician attitudes toward patients with substance use disorders, adoption of buprenorphine, and stigma-reduction interventions for health care professionals and trainees.[2] He has authored or edited texts such as Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment[5] and The Stigma of Addiction: An Essential Guide.[6]

Honors and awards

Selected publications

References

Related Articles

Wikiwand AI